ROBERTS EIRY bought NBIX
February 13, 2025 · Form 4 insider transaction
ROBERTS EIRY bought 2,113 shares of Neurocrine Biosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
2,113
Price
$0.00
Total value
N/A
InsiderROBERTS EIRY
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateFebruary 13, 2025
Filing dateFebruary 14, 2025
Shares owned after35,366
OwnershipDirect
10b5-1 planNo
AmendedNo